Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake?

Hollow Brook Wealth Management sold its entire stake in Bio-Techne — 174,677 shares — in Q4 2025, an estimated $10.7M based on quarterly average pricing. The report is a factual one-off institutional exit and is unlikely to move the stock materially on its own, though it warrants monitoring of broader institutional flows for additional selling pressure.

Analysis

Hollow Brook Wealth Management sold its entire stake in Bio-Techne — 174,677 shares — in Q4 2025, an estimated $10.7M based on quarterly average pricing. The report is a factual one-off institutional exit and is unlikely to move the stock materially on its own, though it warrants monitoring of broader institutional flows for additional selling pressure.